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In these postgenomic days the Protein Data Bank is
featuring protein structures of increasingly large size, thanks to
the progress in the power of the X-ray sources and in the
computer programs to solve X-ray structures.
Yet, there are small proteins whose structures remain
elusive. One of the most striking examples is a stable and
well-folded protein whose existence has been known for nearly
thirty years, whose central importance in eukaryotes
metabolism is undisputed, whose size is ridiculously small (Mr
5655), but whose detailed structure is still unknown. Such
protein is yeast copper thionein (Cu-MT) (Figure 1).
Strange enough, solving this particular structure turned out
to be a puzzle. Molecular replacement techniques using the
protein solution structure as a model failed, probably due to its
lack of eight strong anomalous scatterers (the Cu atoms) and
direct methods could not be applied for phasing because the
resolution, although good, was not at the true atomic level. On
the other hand, the enormous anomalous signal present in the
data (about 20% of the diffracted intensities) could not be
straightforwardly used for the structure solution due to the high
number of anomalous scatterers and to the high symmetry of the
crystal cell (cubic, P4332).
Figure 1
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We isolated and solved the structure of a plasma phosphate
carrier (human). Surprisingly, despite the high importance of
phosphate, none plasma phosphate carrier has been described so
far. Due to the difficulty to obtain heavy atom derivative, we
solved the structure at very-low resolution (25 Å) using a new
direct method requiring neither heavy atom derivative nor
model [1]. The atomic structure was finally solved at 1.8 Å
resolution by classical SIRAS structure determination with one
heavy atom derivative, which was obtained using a new family
of molecule specially designed to produce better heavy atom
derivatives (Kahn et al., in preparation). The structure revealed
two globular domains with a fold very similar to the phosphate
binding proteins of E. coli and M. tuberculosis [2]-[3],
primary ABC phosphate carriers. ABC carriers have been found
in eukaryote kingdom but no primary ABC carrier has been
described in this kingdom.
We showed that this protein is associated to paraoxonase in
human plasma. Paraoxonase is a lipoprotein associated to HDL
("good cholesterol"). This phosphotriestrase is involved in
protection against atherosclerosis development. Knowing that
hyperphosphatemia is a risk factor in atherosclerosis, the human
phosphate binding protein could be a preclinic marker of
cardiovascular pathologies.
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